Rejected at 7:13 p.m. Feb, 02, 2024 ] by herstein.jacob
Author: bkavin
Related Note: 1488847733019 1
Rationale for change

Better describes mechanism. Previous card could accidentally make someone thing its a GP11b antagonist when its not - its an ADP receptor antagonist.
Source: AMBOSS - https://next.amboss.com/us/article/Um0bUg?q=clopidogrel#Zb288dda860ff65493b01ea10fbf1e10c

Rejection reason

This is obvious because it is in the name of the drug - the card is asking what happens as a result of ADP receptor blockade

Text Text
Extra
Clopidogrel and prasugrel are pro-drugs
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy

Watch Antiplatelet Agents
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize




Watch ADP Receptor Inhibitors
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Antiplatelet Medications

Watch associated Bootcamp video - Coagulation and Fibrinolysis: Mixing Studies, Ristocetin, and D-dimer
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::03_Mixing_Studies,_Ristocetin,_and_D-dimer #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::06_ADP_Receptor_Inhibitors #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::05_Antiplatelet_Medications #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::06_Antiplatelets::*ADP_receptor_Inhibitors #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::04_Antiplatelet_Drugs #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::04_Thrombogenesis #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::02_Platelet_Activation::Extra #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_agents #AK_Step1_v12::#UWorld::COMLEX::24937 !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#AMBOSS::T-069i #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::08_Glycoprotein_IIb/IIIa_Inhibitors #AK_Step1_v12::#UWorld::Step::1828 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding